In-Depth Method for the Characterization of Glycosylation in Manufactured Recombinant Monoclonal Antibody Drugs

[Image: see text] The glycosylation in recombinant monoclonal antibody (rMab) drugs is a major concern in the biopharmaceutical industry as it impacts the drugs’ many attributes. Characterization is important but complicated by the intricate structures, microheterogeneity, and the limitations of cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Ting, Ozcan, Sureyya, Becker, Alicia, Lebrilla, Carlito B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066919/
https://www.ncbi.nlm.nih.gov/pubmed/24828102
http://dx.doi.org/10.1021/ac501102t

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066919/
https://www.ncbi.nlm.nih.gov/pubmed/24828102
http://dx.doi.org/10.1021/ac501102t

Ejemplares similares